Doctor Meihua Li
National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)
Donepezil markedly prevents the progression of chronic heart failure and renal dysfunction in renal artery stenosis-induced hypertensive rats
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Chronic Heart Failure ePosters
Oral administration of donepezil markedly prevents the progression of chronic heart failure in renal artery stenosis-induced hypertensive rats
Event: ESC Congress 2019
Topic: Pharmacotherapy
Session: Other cardiovascular disease
Donepezil treatment prevents the progression of cardiac remodeling and dysfunction in obesity-induced hypertensive rats with reperfused myocardial infarction
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Chronic heart failure – Treatment
Oral donepezil markedly suppresses the progression of cardiovascular remodeling and improves the prognosis in spontaneously hypertensive rats with myocardial infarction
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Chronic heart failure – Treatment
Feasibility and efficacy of early donepezil with or without metoprolol in reperfused myocardial infarction rats
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Targeting reverse remodelling in heart failure
Donepezil treatment is superior to metoprolol for improving myocardial salvage and preventing cardiac remodeling in reperfused myocardial infarction rats
Event: ESC Congress 2017
Topic: AHF - Drug treatment
Session: Acute heart failure (AHF)
Vagal stimulation promotes cardiovascular regeneration by activation of endogenous cardiac stem cells in acute myocardial infarction rats
Event: ESC Congress 2016
Topic: Autonomic nervous system and humoral regulations
Session: Autonomic function in hypertension
Early donepezil administration as a novel therapy for improved myocardial salvage after reperfused myocardial infarction
Event: ESC Congress 2016
Topic: Adjunctive medical therapy
Session: Adjunctive medical therapy in coronary artery disease
Contribution of central donepezil to prevention of cardiac dysfunction and improvement of long-term survival in chronic heart failure rats after myocardial infarction
Event: ESC Congress 2016
Topic: Pharmacologic therapy
Session: Novel pharmacological therapy in chronic heart failure
ESC 365 is supported by
